Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	148.59	183.05	226.32	286.47	378.69	465.83
Short-Term Investments	49.36	49.39	50.08	49.94	126.28	12.03
Cash & Short-Term Investments	197.95	232.43	276.4	336.41	504.97	477.86
Cash Growth	-26.91%	-15.91%	-17.84%	-33.38%	5.67%	64.78%
Accounts Receivable	50.06	57.02	34.9	44.06	40.29	26.21
Other Receivables	-	-	-	-	-	2.34
Receivables	50.06	57.02	34.9	44.06	40.29	28.55
Inventory	32.92	28.31	24.08	32.06	39.31	31.8
Prepaid Expenses	22.95	15.2	11.4	11.72	11.91	8.28
Total Current Assets	303.88	332.97	346.78	424.26	596.48	546.5
Property, Plant & Equipment	177.39	151.66	161.35	203.36	214.39	105.7
Long-Term Investments	54.34	54.34	1.53	-	-	-
Goodwill	82.2	82.2	85.81	85.81	85.81	22.43
Other Intangible Assets	13.16	13.43	14.48	54.48	59.74	18.26
Other Long-Term Assets	5.32	5.48	4.38	8.49	4.96	6.18
Total Assets	638.09	641.86	614.32	776.4	961.38	702.1
Accounts Payable	12.49	11.09	1.63	14.05	20.09	14.9
Accrued Expenses	42.24	54.34	48.75	36.57	37.19	28.76
Current Portion of Long-Term Debt	-	-	-	-	-	1.55
Current Portion of Leases	12.24	13.82	14.81	14.9	13.64	8.21
Current Income Taxes Payable	3.9	4.54	2.73	4.37	3.66	2.44
Current Unearned Revenue	9.02	6.88	2.13	3	3.48	1.09
Other Current Liabilities	0.55	0.72	0.96	0.43	12.6	6.1
Total Current Liabilities	80.44	91.41	71.01	73.32	90.66	63.05
Long-Term Debt	15	15	-	-	-	-
Long-Term Leases	85.81	61.75	70.22	79.17	81.27	53.16
Other Long-Term Liabilities	0.74	0.75	0.41	0.48	0.06	5.07
Total Liabilities	181.99	168.9	141.63	152.97	171.99	121.28
Additional Paid-In Capital	1,807	1,793	1,715	1,657	1,620	1,191
Retained Earnings	-1,350	-1,320	-1,242	-1,033	-828.42	-610.55
Comprehensive Income & Other	-0.57	-0.63	-0.52	-0.76	-1.84	0.55
Total Common Equity	456.1	472.96	472.69	623.43	789.39	580.82
Shareholders' Equity	456.1	472.96	472.69	623.43	789.39	580.82
Total Liabilities & Equity	638.09	641.86	614.32	776.4	961.38	702.1
Total Debt	113.05	90.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	84.9	141.86	191.37	242.34	410.06	414.94
Net Cash Growth	-50.98%	-25.87%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	1.41	2.37	3.30	4.26	7.61	8.60
Filing Date Shares Outstanding	61.31	61.15	59.36	57.67	56.57	49.63
Total Common Shares Outstanding	61.27	60.63	58.88	57.56	56.52	49.5
Working Capital	223.44	241.56	275.77	350.93	505.82	483.44
Book Value Per Share	7.44	7.80	8.03	10.83	13.97	11.73
Tangible Book Value	360.74	377.34	372.4	483.14	643.84	540.13
Tangible Book Value Per Share	5.89	6.22	6.33	8.39	11.39	10.91
Machinery	111.9	107.88	105.93	111.18	67.43	53.61
Construction In Progress	17.69	20.12	4.69	8.53	87.72	16.97
Leasehold Improvements	64.69	58.28	57.45	57.27	14.37	5.07

Updated Feb 2, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q